Stephen T Ferris

10PUBLICATIONS
69CO-AUTHORS
Haematological tumoursCancer cell biologyMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 25, 2026
Reduced Tumor Control in Males Can Result from Impaired CD4+ T-cell Help through the CD40L-CD40 Pathway.

Katey S Hunt, Samantha Cooke, Lindsey M Kuehm

|May 02, 2024
T-Cell Expression of CXCL13 is Associated with Immunotherapy Response in a Sex-Dependent Manner in Patients with Lung Cancer.

Michelle Brennan, David DeBruin, Chinye Nwokolo

|Jul 11, 2023
IL-6 selectively suppresses cDC1 specification via C/EBPβ.

Sunkyung Kim, Jing Chen, Suin Jo

|Feb 16, 2023
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.

Mingyu He, Kate Roussak, Feiyang Ma

|Oct 21, 2022
Mechanisms of CD40-dependent cDC1 licensing beyond costimulation.

Renee Wu, Ray A Ohara, Suin Jo

|Jun 22, 2022
Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.

Tian-Tian Liu, Sunkyung Kim, Pritesh Desai

Pageof 2

Frequent Collaborators

6 joint publications

Kenneth M Murphy

4 joint publications

Tian-Tian Liu

3 joint publications

Ray A Ohara

3 joint publications

Renee Wu